17 September 2020 - The PHARMAC model is broken, according to an advocate for increased access to life-saving drugs in New Zealand, and will lead to a stagnant life expectancy for cancer-stricken or chronically ill Kiwis.
Patient Voice Aotearoa chairman and the advocate behind the Sign4Life petition, Malcolm Mullholland, is campaigning to double the budget for PHARMAC - the agency that decides which medicines are subsidised for public use in New Zealand - in order to fund transformative medications for critically ill Kiwis.